Evidence map›Paper›PMID 32204550›Full record

ArticleInternational journal of molecular sciences2020

Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix.

Saioa Mendaza, Joaquín Fernández-Irigoyen, Enrique Santamaría, Tamara Zudaire, Rosa Guarch, David Guerrero-Setas, August Vidal, José Santos-Salas, Xavier Matias-Guiu, Karina Ausín and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. CSDE1 Intracellular Distribution as a Biomarker of Melanoma Prognosis.International journal of molecular sciences · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Frontiers in oncology · 2021
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Saioa MendazaMolecular Pathology of Cancer Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
Joaquín Fernández-IrigoyenProteored-ISCIII, Proteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
Enrique SantamaríaProteored-ISCIII, Proteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.ORCID 0000-0001-8046-8102
Tamara ZudaireDepartment of Pathology, Complejo Hospitalario de Navarra (CHN), Irunlarrea 3, 31008 Pamplona, Spain.
Rosa GuarchDepartment of Pathology, Complejo Hospitalario de Navarra (CHN), Irunlarrea 3, 31008 Pamplona, Spain.
David Guerrero-SetasMolecular Pathology of Cancer Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
August VidalDepartment of Pathology, Hospital Universitari de Bellvitge, IDIBELL, Carrer de la Feixa Llarga, 08907 L'Hospitalet de Llobregat, Spain.ORCID 0000-0001-5727-2099
José Santos-SalasDepartment of Pathology, Complejo Asistencial Universitario, Altos de Nava, 24071 León, Spain.ORCID 0000-0002-7488-2013
Xavier Matias-GuiuDepartment of Pathology, Hospital Universitari de Bellvitge, IDIBELL, Carrer de la Feixa Llarga, 08907 L'Hospitalet de Llobregat, Spain.
Karina AusínProteored-ISCIII, Proteomics Unit, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.
María José Díaz de CerioDepartment of Pathology, Complejo Hospitalario de Navarra (CHN), Irunlarrea 3, 31008 Pamplona, Spain.
Esperanza Martín-SánchezMolecular Pathology of Cancer Group, Navarrabiomed, Complejo Hospitalario de Navarra (CHN), Universidad Pública de Navarra (UPNA), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Irunlarrea 3, 31008 Pamplona, Spain.ORCID 0000-0002-8155-9185
Universidad Publica de Navarra · ESComplejo Hospitalario de Navarra · ESBellvitge University Hospital · ESComplejo Asistencial Universitario de Palencia · ESUniversitat de Lleida · ES

Funding

Health Department of the Navarre Government 21/11Navarre Breast Cancer Patients' Association (SARAY) SARAYProteored, PRB3-ISCIII (ISCIII and ERDF) PT17/0019/009Proteored: "Proof of concept project on proteomic research" ProteoRed-0000029Public University of Navarre (predoctoral grant)Spanish Ministry of Science, Innovation and Universities PTA2015-11895-I
6 · The paper itself

Abstract

The tumor-suppressor protein p16 is paradoxically overexpressed in cervical cancer (CC). Despite its potential as a biomarker, its clinical value and the reasons for its failure in tumor suppression remain unclear. Our purpose was to determine p16 clinical and biological significance in CC. p16 expression pattern was examined by immunohistochemistry in 78 CC cases (high-grade squamous intraepithelial lesions (HSILs) and squamous cell carcinomas of the cervix -SCCCs). CC cell proliferation and invasion were monitored by real-time cell analysis and Transwell

Indexed as

Biomarkers, TumorCarcinoma, Squamous CellCell Line, TumorCell NucleusCyclin-Dependent Kinase Inhibitor p16FemaleHeLa CellsHumansImmunohistochemistryMiddle AgedPrognosisSensitivity and SpecificitySurvival AnalysisUterine Cervical NeoplasmsBiomarkers, TumorCyclin-Dependent Kinase Inhibitor p16cervical cancercytoplasmic p16high-grade squamous intraepithelial lesionnuclear p16predictive biomarkersquamous cell carcinoma of the cervixsubcellular location

Identifiers

PMID32204550
PMCPMC7139571
OpenAlexW3010925371

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.